CytoMed Therapeutics Limited (GDTC) Open Interest History

Open interest tracks the total number of outstanding options contracts. Rising OI alongside price moves can indicate growing commitment to the trend; declining OI suggests positions are being closed.

CytoMed Therapeutics Limited (GDTC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $12.1M, listed on NASDAQ, employing roughly 42 people, carrying a beta of 0.02 to the broader market. CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. Led by Chee Kong Choo, public since 2023-04-14.

Open interest history tracks how outstanding options contracts change over time. No recent options activity for GDTC as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how open interest is reported and how to read the data →